Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous Melanoma

Gabriel Alves Freiria de Oliveira, Daniel Arcuschin de Oliveira, Melissa Yoshimi Sakamoto Maeda Nisimoto, Rafael Rubinho, Heitor Carvalho Gomes, Luciana Cavalheiro Marti, Renato Santos de Oliveira Filho · 2024

Read Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous Melanoma by Gabriel Alves Freiria de Oliveira, Daniel Arcuschin de Oliveira, Melissa Yoshimi Sakamoto Maeda Nisimoto, Rafael Rubinho, Heitor Carvalho Gomes, Luciana Cavalheiro Marti, Renato Santos de Oliveira Filho (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641307.txt.

Description

Gabriel Alves Freiria de Oliveira and co-authors review a cell therapy for advanced skin melanoma in a 2024 paper. Melanoma is a small share of skin tumors but causes most skin cancer deaths. Even with modern immune and targeted drugs, over half of invasive cases end in death from resistance.

The therapy grows a patient's own tumor-infiltrating lymphocytes, immune cells already inside the tumor, and returns them in force. The review covers how these cells also serve as a prognostic sign, since their presence hints at the body's own fight. It surveys recent trial outcomes for patients whose disease kept growing on standard care.

Catalog record

CREATORGabriel Alves Freiria de Oliveira, Daniel Arcuschin de Oliveira, Melissa Yoshimi Sakamoto Maeda Nisimoto, Rafael Rubinho, Heitor Carvalho Gomes, Luciana Cavalheiro Marti, Renato Santos de Oliveira Filho
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11641307

Browse the full library · About the Tower of Babel